MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$129,817K
Interest and other
income, net
$8,816K
Net loss
-$129,766K
Unrealized gain (loss) on
available-for-sale securities
-$51K
Total other income
$6,047K
Interest expense
$2,769K
Loss from operations
-$135,813K
Collaboration and license
revenue
$10,325K
Total operating
expenses
$146,138K
Research and development
$114,150K
General and
administrative
$31,988K
Back
Back
Income Statement
source: myfinsight.com
TScan Therapeutics, Inc. (TCRX)
TScan Therapeutics, Inc. (TCRX)